Clinical trial

Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where…

NCT00145704 · State University of New York - Upstate Medical University, Other · Terminated

Key facts

NCT number NCT00145704
Title Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density
Official title Treatment of Childhood Cancer Therapy-induced Osteopenia in Growth Hormone Deficient Adult Survivors: Does Bisphosphonate Treatment Improve Bone Mineral Density?
Lead sponsor State University of New York - Upstate Medical University, Other
Collaborators Genentech, Inc. Industry
Status Terminated
Study type Interventional
Conditions Osteopenia
Intervention type Dietary Supplement, Drug
Interventions bisphosphonate therapy (risedronate), Vitamin D supplement, Calcium
Enrollment 6
Start date Jun 1, 2002
Primary completion Oct 1, 2008
Completion Oct 1, 2008
First posted Sep 5, 2005
Last update posted Apr 8, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies